Non-Hodgkin’s Lymphomas, Version 1.2013
Andrew D. Zelenetz(Memorial Sloan Kettering Cancer Center), Maoko Naganuma(National Comprehensive Cancer Network), Leo I. Gordon(Northwestern University), Barbara Pro(The University of Texas MD Anderson Cancer Center), Nancy L. Harris(World Resources Institute), Nadeem Zafar(University of Tennessee Health Science Center), Oliver W. Press(Fred Hutch Cancer Center), Luis Fayad(The University of Texas MD Anderson Cancer Center), Susan Krivacic(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Lubomir Sokol(Moffitt Cancer Center), Pierluigi Porcu(Thomas Jefferson University), Naresh Bellam(University of Alabama at Birmingham), Ranjana H. Advani(Stanford Medicine), Christina Tsien(McGill University Health Centre), Charalambos Andreadis(University of California, San Francisco), Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), Richard T. Hoppe(Stanford Medicine), Nancy L. Bartlett(Washington University in St. Louis), Julie M. Vose(University of Nebraska Medical Center), Nishitha Reddy(Vanderbilt University), Ann S. LaCasce(Otsuka (Japan)), Youn H. Kim(Stanford University), Jon P. Gockerman, John C. Byrd, William G. Wierda(The University of Texas MD Anderson Cancer Center), Myron S. Czuczman(Roswell Park Comprehensive Cancer Center), Mary A. Dwyer(National Comprehensive Cancer Network), Christopher R Kelsey(Cancer Institute (WIA)), Auayporn Nademanee(City Of Hope National Medical Center), Martha Glenn(Huntsman Cancer Institute), Jeremy S. Abramson(Massachusetts General Hospital), Lode J. Swinnen(Johns Hopkins University), Joachim Yahalom(Unknown)
Cited by 76
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k